Cargando…

A brain-targeting lipidated peptide for neutralizing RNA-mediated toxicity in Polyglutamine Diseases

Polyglutamine (PolyQ) diseases are progressive neurodegenerative disorders caused by both protein- and RNA-mediated toxicities. We previously showed that a peptidyl inhibitor, P3, which binds directly to expanded CAG RNA can inhibit RNA-induced nucleolar stress and suppress RNA-induced neurotoxicity...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qian, Yang, Mengbi, Sørensen, Kasper K., Madsen, Charlotte S., Boesen, Josephine T., An, Ying, Peng, Shao Hong, Wei, Yuming, Wang, Qianwen, Jensen, Knud J., Zuo, Zhong, Chan, Ho Yin Edwin, Ngo, Jacky Chi Ki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608758/ https://www.ncbi.nlm.nih.gov/pubmed/28935901 http://dx.doi.org/10.1038/s41598-017-11695-y

Ejemplares similares

A peptidylic inhibitor for neutralizing expanded CAG RNA-induced nucleolar stress in polyglutamine diseases
por: Zhang, Qian, et al.
Publicado: (2018)

Molecular insights into the interaction of CAG trinucleotide RNA repeats with nucleolin and its implication in polyglutamine diseases
por: An, Ying, et al.
Publicado: (2022)

Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila
por: Zhang, Qian, et al.
Publicado: (2016)

Praja1 ubiquitin ligase facilitates degradation of polyglutamine proteins and suppresses polyglutamine-mediated toxicity
por: Ghosh, Baijayanti, et al.
Publicado: (2021)

CAG RNAs induce DNA damage and apoptosis by silencing NUDT16 expression in polyglutamine degeneration
por: Peng, Shaohong, et al.
Publicado: (2021)

Candida albicans Is Resistant to Polyglutamine Aggregation and Toxicity
por: Leach, Michelle D., et al.
Publicado: (2016)

Formation and Toxicity of Soluble Polyglutamine Oligomers in Living Cells
por: Lajoie, Patrick, et al.
Publicado: (2010)

Calpain-mediated proteolysis as driver and modulator of polyglutamine toxicity
por: Incebacak Eltemur, Rana Dilara, et al.
Publicado: (2022)

Overview of Pharmacokinetics and Liver Toxicities of Radix Polygoni Multiflori
por: Li, Dan, et al.
Publicado: (2020)

Polyglutamine Toxicity Is Controlled by Prion Composition and Gene Dosage in Yeast
por: Gong, He, et al.
Publicado: (2012)

RNA toxicity in polyglutamine disorders: concepts, models, and progress of research
por: Fiszer, Agnieszka, et al.
Publicado: (2013)

Polyglutamine toxicity in yeast induces metabolic alterations and mitochondrial defects
por: Papsdorf, Katharina, et al.
Publicado: (2015)

Interferon mediated neuroinflammation in polyglutamine disease is not caused by RNA toxicity
por: Bhambri, Aksheev, et al.
Publicado: (2020)

Relationships between the Toxicities of Radix Aconiti Lateralis Preparata (Fuzi) and the Toxicokinetics of Its Main Diester-Diterpenoid Alkaloids
por: Yang, Mengbi, et al.
Publicado: (2018)

A network of genes connects polyglutamine toxicity to ploidy control in yeast
por: Kaiser, Christoph J.O., et al.
Publicado: (2013)

Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity
por: Menzies, F M, et al.
Publicado: (2015)

Autophagy and polyglutamine diseases
por: Jimenez-Sanchez, Maria, et al.
Publicado: (2012)

Polyglutamine Repeats in Viruses
por: Schein, Catherine H.
Publicado: (2018)

Celastrol inhibits polyglutamine aggregation and toxicity though induction of the heat shock response
por: Zhang, Yu-Qian, et al.
Publicado: (2007)

Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease
por: Rose, Claudia, et al.
Publicado: (2010)

Polyglutamine toxicity assays highlight the advantages of mScarlet for imaging in Saccharomyces cerevisiae
por: Albakri, Maram B., et al.
Publicado: (2018)

Synergistic activation of AMPK prevents from polyglutamine-induced toxicity in Caenorhabditis elegans
por: Gómez-Escribano, AP, et al.
Publicado: (2020)

RNA-mediated pathogenic mechanisms in polyglutamine diseases and amyotrophic lateral sclerosis
por: Chan, Ho Yin Edwin
Publicado: (2014)

A peptide inhibitor that rescues polyglutamine-induced synaptic defects and cell death through suppressing RNA and protein toxicities
por: Peng, Shaohong Isaac, et al.
Publicado: (2022)

Pharmacological Activation of Sirt1 Ameliorates Polyglutamine-Induced Toxicity through the Regulation of Autophagy
por: Shin, Bae Hyun, et al.
Publicado: (2013)

Large-Scale Screen for Modifiers of Ataxin-3-Derived Polyglutamine-Induced Toxicity in Drosophila
por: Voßfeldt, Hannes, et al.
Publicado: (2012)

Attenuation of polyglutamine-induced toxicity by enhancement of mitochondrial OXPHOS in yeast and fly models of aging
por: Ruetenik, Andrea L., et al.
Publicado: (2016)

An Exploration of the Universe of Polyglutamine Structures
por: Gómez-Sicilia, Àngel, et al.
Publicado: (2015)

The Relationship between Aggregation and Toxicity of Polyglutamine-Containing Ataxin-3 in the Intracellular Environment of Escherichia coli
por: Invernizzi, Gaetano, et al.
Publicado: (2012)

Multiple discrete soluble aggregates influence polyglutamine toxicity in a Huntington’s disease model system
por: Xi, Wen, et al.
Publicado: (2016)

Salidroside Protects Caenorhabditis elegans Neurons from Polyglutamine-Mediated Toxicity by Reducing Oxidative Stress
por: Xiao, Lingyun, et al.
Publicado: (2014)

Skeletal Muscle Pathogenesis in Polyglutamine Diseases
por: Marchioretti, Caterina, et al.
Publicado: (2022)

A Peptidylic Inhibitor for Neutralizing (r)(GGGGCC)(exp)-Associated Neurodegeneration in C9ALS-FTD
por: Zhang, Qian, et al.
Publicado: (2019)

Tissue Accumulations of Toxic Aconitum Alkaloids after Short-Term and Long-Term Oral Administrations of Clinically Used Radix Aconiti Lateralis Preparations in Rats
por: Ji, Xiaoyu, et al.
Publicado: (2019)

Natural genetic variation determines susceptibility to aggregation or toxicity in a C. elegans model for polyglutamine disease
por: Gidalevitz, Tali, et al.
Publicado: (2013)

An Engineered Viral Protease Exhibiting Substrate Specificity for a Polyglutamine Stretch Prevents Polyglutamine-Induced Neuronal Cell Death
por: Sellamuthu, Saravanan, et al.
Publicado: (2011)

Development of mAb-based polyglutamine-dependent and polyglutamine length-independent huntingtin quantification assays with cross-site validation
por: Fischer, David F., et al.
Publicado: (2022)

GULP1/CED-6 ameliorates amyloid-β toxicity in a Drosophila model of Alzheimer’s disease
por: Vivien Chiu, Wai Yin, et al.
Publicado: (2017)

Polyglutamine Leads to Altered Chromatin Architecture and Neurodegeneration
por: Robinson, Richard
Publicado: (2006)

Molecular Origin of Polyglutamine Aggregation in Neurodegenerative Diseases
por: Khare, Sagar D, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_nb9o39pl3kitrvi1gv8m1sirgj